Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Xiao-Mei She"'
Publikováno v:
Carcinogenesis. 34:426-435
Deregulated microRNAs (miRNAs) and their roles in cancer development have attracted much attention. Two miRNAs, miR-15a and miR-16, which act as putative tumor suppressor by targeting the oncogene BCL2, have been implicated in cell cycle, apoptosis a
Autor:
Fu-Rong Lu, Nicholas M. Gregg, Tao Guo, Yu Hu, Xiao-Mei She, Xiang-Rong Shu, You Qin, Lei Chen, Di Yang, Chunyan Sun
Publikováno v:
Leukemia Research. 36:514-520
NF-κB plays a major role in the pathology of multiple myeloma. Here, we intended to investigate the regulating effect of cardamonin on NF-κB in myeloma cells. We found for the first time that cardamonin suppressed viability and induced apoptosis of
Publikováno v:
International Journal of Cancer. 130:827-836
Multiple myeloma (MM) is characterized by accumulation of monoclonal plasma cells in the bone marrow and progression of lytic bone lesions. The mechanisms of enhanced bone resorption in patients with myeloma are not fully defined. We have previously
Publikováno v:
Tumor Biology. 31:121-128
This study investigated the signaling pathways involved in the different biological effects of brain-derived neurotrophic factor (BDNF) in multiple myeloma (MM). The effects of BDNF on proliferation of MM cell lines and primary myeloma cells were exa
Publikováno v:
Yonsei Medical Journal
Purpose The objective was to determine the characteristics and prognostic factors of 86 Chinese patients with trisomy 8 aberrations and compare the prognostic value of International Prognostic System (IPSS) and Revised IPSS (IPSS-R) in this cohort. M
Publikováno v:
Chinese medical journal. 124(19)
Chromosome 13q14 deletion (del13q14), chromosome 1q21 gain (amp1q21) and chromosome 17p13 deletion (del17p13) are the most frequent chromosomal aberrations in multiple myeloma (MM). They play an important role in prognosis. The aim of this study was
Publikováno v:
Yonsei Medical Journal; Mar2016, Vol. 57 Issue 2, p358-364, 7p
Autor:
Nicholas M. Gregg, You Qin, Xiao-Mei She, Lei Chen, Yadan Wang, Tao Guo, Lu Zhang, Han Yan, Lisha Ai, Yu Hu, Jun Fang, Chunyan Sun
Publikováno v:
Blood. 116:1820-1820
Abstract 1820 Background and Objective: Although there have been introductions of novel and more potent therapeutic regimens, multiple myeloma (MM) remains an incurable hematological malignant disorder. Current goals in MM treatment are focused on fi
Publikováno v:
Blood. 116:1917-1917
Abstract 1917 Background and Objective: Multiple myeloma (MM) is characterized by accumulation of monoclonal plasma cells in the bone marrow and progression of lytic bone lesions. The mechanisms of enhanced bone resorption in patients with myeloma ar
Publikováno v:
Blood. 116:4039-4039
Abstract 4039 MicroRNAs (miRNAs) are non-coding small RNAs that negatively modulate protein expression at a post-transcriptional level and are deeply involved in the pathogenesis of a variety of cancers. Two miRNAs, miR-15a and miR-16, which act as p